For patients with disorders such as autism and schizophrenia, mutations in the same gene could require different treatments, according to new research from Yale School of Medicine (YSM).

NEW YORK CITY, NEW YORK / ACCESS Newswire / April 22, 2025 / Neurovation Labs, Inc., a precision neuroscience biotechnology company targeting physiological biomarkers of Post-traumatic Stress Disorder ...

NEW YORK CITY, NEW YORK / ACCESS Newswire / April 22, 2025 /Neurovation Labs, Inc., a precision neuroscience biotechnology ...

The efficacy of individual treatment approaches with contrasting cholinergic and glutamatergic mechanisms of action prompted investigation of the effects of targeting both systems for the ...

When focused on OCD-specific trials, glutamatergic medications are associated with significantly decreased scores on the Yale-Brown Obsessive Compulsive Scale. Glutamatergic medications may ...

19neurotransmitters_163ROIs_AICHA_asym_zScored.csv corresponds to the asymmetry of 19 neurotransmitter systems maps (see Hansen, J. Y., et al. 2022) for each of the 163 regions of the AICHA atlas . 24 ...

Division of Cardiology, Department of Medicine, University of California, Los Angeles (H.M.S., K.E.J., T.Q.d.A.V., E.J.T.). Division of Cardiology, Department of ...

The authors provide valuable insights into the candidate upstream transcriptional regulatory factors that control the spatiotemporal expression of selector genes and their targets for GABAergic vs ...

Get Instant Summarized Text (Gist) A novel drug compound has been identified that selectively activates delta opioid receptors, offering pain relief without the dangerous side effects associated ...

Using an elegant and thorough experimental design, Thomazeau et al show that, in the developing mouse visual cortex, presynaptic NMDA receptors at layer 5 neocortical synapses mediate spike-timing ...